60
Participants
Start Date
February 14, 2024
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2033
18F-FDG
Each subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to two weeks depending on subject, imaging agent and scanner availability.
11C-butanol
Each subject will undergo a dynamic 18F-FDG PET/CT scan (this drug is FDA approved) and a dynamic 11C-butanol PET/CT scan (this drug is under an IND) on the EXPLORER total-body PET/CT system. The two scans will be performed on the same day or within a period of up to two weeks depending on subject, imaging agent and scanner availability.
RECRUITING
UC Davis EXPLORER Molecular Imaging Center, Sacramento
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
NIH
University of California, Davis
OTHER